These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2512134)

  • 1. First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject.
    Bürgisser P; Odier L; Schüpbach J; Frei PC
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):889-92. PubMed ID: 2512134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2.
    Ayres L; Avillez F; Garcia-Benito A; Deinhardt F; Gürtler L; Denis F; Léonard G; Ranger S; Grob P; Joller-Jemelka H
    AIDS; 1990 Feb; 4(2):131-8. PubMed ID: 2183814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
    Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB
    Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human immunodeficiency virus type 2 infection in Western Africans living in Catalonia].
    Soriano V; Tor J; Muga R; Fernández JL; Ribera A; Balanzó X; Foz M
    Med Clin (Barc); 1989 Feb; 92(5):161-3. PubMed ID: 2657255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for antibodies to human immunodeficiency virus type 2 in the United States.
    O'Brien TR; George JR; Epstein JS; Holmberg SD; Schochetman G
    MMWR Recomm Rep; 1992 Jul; 41(RR-12):1-9. PubMed ID: 1324395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of six different commercial assays to demonstrate antibodies to HIV-2 among immigrants from high-endemic areas.
    Skaug K; Ulstrup JC; Espinoza R
    Scand J Infect Dis; 1990; 22(3):373-4. PubMed ID: 2371550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of human immunodeficiency virus 2 infection into South Korea.
    Kim SS; Kim EY; Park KY; Suh SD; Park HK; Shin YO; Bae M; Lee JS
    Acta Virol; 2000 Feb; 44(1):15-22. PubMed ID: 10989687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides.
    Pollet DE; Saman EL; Peeters DC; Warmenbol HM; Heyndrickx LM; Wouters CJ; Beelaert G; van der Groen G; Van Heuverswyn H
    Clin Chem; 1991 Oct; 37(10 Pt 1):1700-7. PubMed ID: 1914169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type II (HIV-2) testing: a perspective.
    Glassman AB
    Ann Clin Lab Sci; 1992; 22(5):283-5. PubMed ID: 1524400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot.
    Barbé F; Klein M; Badonnel Y
    Ann Biol Clin (Paris); 1994; 52(5):341-5. PubMed ID: 7856933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Could saliva be used to detect HIV seroconversion?].
    Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
    Sante; 1997; 7(5):303-7. PubMed ID: 9480036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying HIV-2-seropositive individuals by reevaluating HIV-1 indeterminate sera.
    Myers RA; Patel JD; Joseph JM
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):417-23. PubMed ID: 1548577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring blood donors for HIV-2 infection by testing anti-HIV-1 reactive sera.
    Busch MP; Petersen L; Schable C; Perkins H
    Transfusion; 1990 Feb; 30(2):184-7. PubMed ID: 1968296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of HIV-1 and HIV-2 indeterminate western blot patterns.
    Ayisi NK; Aidoo M
    West Afr J Med; 1994; 13(3):164-7. PubMed ID: 7841107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of a competitive enzyme immunoassay with Western blot in the detection of anti-HIV-1].
    Pineda JA; Calderón E; Rey C; Leal M
    Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):60-2. PubMed ID: 2095909
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS: recommendations for the interpretation of HIV-2 western blot results.
    Bull World Health Organ; 1990; 68(4):515, 519. PubMed ID: 2208564
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay.
    Montesinos I; Eykmans J; Delforge ML
    J Clin Virol; 2014 Aug; 60(4):399-401. PubMed ID: 24932737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of a new test for detection of antibodies to HIV-1/-2 in blood donors].
    Saadé C; Wüst T
    Infusionsther Transfusionsmed; 1996 Jun; 23(3):133-7. PubMed ID: 8924748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.